Nuvalent Inc

NASDAQ:NUVLUnited States

06:53 AM EST, 11/12/2024 (MT Newswires) -- Nuvalent (NUVL) reported a Q3 net loss Tuesday of $1.28 per diluted share, widening from a loss of $0.59 a year earlier. Analysts polled by Capital IQ expected a loss of $0.93. The clinical-stage biopharmac...

Net loss $ (84,345) $ (33,645) $ (185,993) $ (87,927) ------------------------- ------------------------- ----------------------- ----------------------- Net loss per share attributable to common stockholders, basic and diluted $ (1.28) $ (0.59) $ (2.87) $ (1.55) ------------------------- ------------------------- ----------------------- ----------------------- Weighted average shares of common stock outstanding, basic and diluted 65,678,693 57,091,394 64,814,695 56,888,839 ------------------------- ------------------------- ----------------------- ----------------------- SELECTED BALANCE SHEET DATA (In thousands) (Unaudited) September 30, December 31, 2024 2023 ------------------------------- ------------------------------- Cash, cash equivalents and marketable securities $ 1,168,309 $ 719,905 Working capital $ 1,128,543 $ 694,665 Total assets $ 1,188,858 $ 732,384 Total liabilities $ 67,732 $ 31,823 Total stockholders' equity $ 1,121,126 $ 700,561